Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration
PHASE1
A multicenter clinical study to evaluate the safety, PK characteristics, im...
Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
PHASE2
The primary purpose of this study is to evaluate the efficacy and safety of...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China, Hefei, Recruiting
A Study of Baricitinib (LY3009104) in Healthy Chinese Participants
PHASE1
The main purpose of this study is to investigate the safety and tolerabilit...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.